Wei Xu

Dr. Wei Xu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZZZhu Zhu
Zhu Zhu
YFYa-Dong Feng
Ya-Dong Feng
YZYun-Lu Zou
Yun-Lu Zou
YXYing-Hao Xiao
Ying-Hao Xiao
JWJia-Jun Wu
Jia-Jun Wu
WXWei Xu
Wei Xu

Verified
Journal Article
Open access
PDF file
XLXinmeng Lin
Xinmeng Lin
XDXuehui Ding
Xuehui Ding
YZYunlu Zou
Yunlu Zou
MSMingyang Sheng
Mingyang Sheng
JLJingying Li
Jingying Li
WXWei Xu
Wei Xu
Sinomenine (SIN), as a potential therapeutic agent for rheumatoid arthritis (RA), exhibits advantages such as non-addictiveness. However, its low aqueous solubility and poor membrane permeability result in limited bioavailability, which compromises its therapeutic efficacy in conventional formulations. To address these limitations, this study developed nanostructured lipid carriers (NLCs) with optimized formulations and evaluated their pharmacodynamic performance. Molecular dynamics (MD) simulations were employed to screen excipients and analyze the blending system. SIN-loaded NLCs (SIN-NLCs) were prepared using high-pressure homogenization. Single-factor experiments were performed to optimize the processing conditions of SIN-NLCs. A three-factor, three-level experimental design was established using Design Expert 13 software and further refined through Box–Behnken design (BBD) response surface methodology. This approach enabled cross-validation between molecular dynamics simulations and conventional experiments. Additionally, transmission electron microscopy (TEM) was used to examine morphology, while X-ray diffraction analysis (XRD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FT-IR) were employed to characterize the physicochemical state of SIN in NLCs. Pharmacodynamic evaluation was performed in a RA model, supplemented by single-pass intestinal perfusion study (SPIP). Initially, MD simulations were employed to evaluate drug–excipient compatibility, thereby identifying suitable formulation excipients: stearic acid and oleic acid as lipid components, and Poloxamer 188 as the surfactant. Subsequently, single-factor experiments combined with the BBD response surface methodology were employed to optimize preparation parameters, establishing the ideal process conditions: drug-to-lipid ratio of 1:42, solid-to-liquid lipid ratio of 5.58:4.42, and Poloxamer 188 concentration of 1.20%. The optimized SIN-NLCs exhibited spherical particles with uniform dispersion and no agglomeration. The average particle size was 173.90 ± 1.97 nm, with a polydispersity index (PDI) of 0.18 ± 0.01, a zeta potential of −22.65 ± 0.60 mV, and an encapsulation efficiency (EE%) of 91.27% ± 0.01. Spectroscopic analysis confirmed that SIN existed in an amorphous state and was successfully encapsulated within the lipid matrix. In vivo, SIN-NLCs significantly reduced paw swelling and arthritis scores in model rats, promoted synovial cell proliferation, and suppressed inflammatory cell infiltration. The intestinal perfusion study demonstrated that SIN-NLCs were primarily absorbed in the small intestine and markedly enhanced drug permeability. SIN-NLCs represent an effective delivery system to enhance the solubility and permeability of SIN. This study provides a novel strategy and methodology for the formulation of hydrophobic drugs, offering valuable insights for future pharmaceutical development.

Verified
Journal Article
Open access
PDF file
JZJiaoyue Zhu
Jiaoyue Zhu
JLJingying Li
Jingying Li
YZYunlu Zou
Yunlu Zou
XDXuehui Ding
Xuehui Ding
JLJixin Li
Jixin Li
WXWei Xu
Wei Xu
Sinomenine (SIN) is a promising candidate for the treatment of rheumatoid arthritis (RA). Although it possesses the advantage of being non-addictive, its poor aqueous solubility and low oral bioavailability have limited its clinical application. To address these issues, SIN was encapsulated into lipid cubic liquid crystal nanoparticles (LCNPs) and systematically characterized. Molecular dynamics (MD) simulations were first employed to screen suitable excipients for formulation development. Combined with single-factor optimization and Box–Behnken response surface design, the optimal composition and preparation process were determined. The resulting SIN-LCNPs exhibited a particle size of 149.7 ± 0.9 nm, a polydispersity index (PDI) of 0.223 ± 0.01, a zeta potential of −18.9 mV, and an encapsulation efficiency (EE%) of 92.2%. Spectroscopic analyses confirmed successful incorporation of SIN into the lipid matrix. Pharmacodynamic studies revealed that SIN-LCNPs enhanced targeted drug delivery to inflamed joints, significantly alleviating inflammation and suppressing disease progression in rats. In vivo single-pass intestinal perfusion (SPIP) experiments further demonstrated that SIN was primarily absorbed through the small intestine and that the LCNP carrier effectively improved its intestinal permeability. Collectively, this study provides a novel strategy and theoretical foundation for developing efficient formulations of poorly water-soluble drugs, highlighting the potential clinical application of SIN-LCNPs in RA therapy.

Verified
Journal Article
Open access
PDF file
YKYiran Kang
Yiran Kang
WSWei Shen
Wei Shen
SPShili Pan
Shili Pan
HLHaiying Lian
Haiying Lian
XDXuehui Ding
Xuehui Ding
WXWei Xu
Wei Xu
Sinomenine (SIN) is a drug for the treatment of rheumatoid arthritis, most of which is administered orally, but it is prone to adverse gastrointestinal effects. Gel can overcome the gastrointestinal adverse effects caused by oral administration. In this paper, a multiscale computational pharmaceutics strategy was developed to guide the systematic study of formulation factors of a SIN gel and, further, to guide the formulation design. A molecular dynamics (MD) simulations method was utilized to successfully screen the optimal prescription of SIN gel and to elucidate the molecular mechanisms affecting the quality of SIN gel. The optimal prescription was 3.0% of SIN, 1.0% of Carbopol (Cp), 30% of Ethanol (Eth), 5.0% of Glycerine (Gly) and 10.0% of Menthol (Men). The influence mechanism can be explained by the combination of multiple parameters, such as the microstructure diagram, the radius of gyration (Rg) and the radial distribution function (RDF). In vitro transdermal studies were carried out using a modified Franz diffusion cell method to evaluate the quality of the screened and reference prescriptions. The results showed that the cumulative penetration and penetration rate of the screening of prescription were better than the reference formulation. Most important of all, the simulation results are in good agreement with the in vitro release experiment, indicating that the strategy has good applicability. This study was able to accurately optimize the formulation and elucidate the molecular mechanism, which would provide a reference for further research on SIN and gel.

8 August 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YZYunlu Zou
Yunlu Zou
ZYZidong Yang
Zidong Yang
JLJiatong Liu
Jiatong Liu
MSMingyang Sheng
Mingyang Sheng
ZWZhenzhou Wang
Zhenzhou Wang
WXWei Xu
Wei Xu

Verified
Journal Article
Open access
PDF file
HYHongyang You
Hongyang You
YZYunlu Zou
Yunlu Zou
JLJiatong Liu
Jiatong Liu
YXYinghao Xiao
Yinghao Xiao
JLJixin Li
Jixin Li
WXWei Xu
Wei Xu
Triclosan (TCS) is a widely used antimicrobial and endocrine-disrupting chemical whose potential relevance to prostate cancer (PCa) biology remains insufficiently understood. We integrated multi-omics and computational analyses to identify candidate targets that overlap between predicted TCS-related molecular targets and PCa-related transcriptomic alterations. Cross-database target mapping, differential expression, and network analyses were combined with machine learning, molecular docking, molecular dynamics simulations, Mendelian randomization, and single-cell transcriptomic profiling. Pathway analyses highlighted oxidative stress and metabolic dysregulation as key processes shared between predicted TCS-related targets and PCa-associated transcriptomic alterations. Machine learning prioritized five candidate genes—FERMT2, F5, PRKCA, ABCC4, and ACOX2—with discriminative value for PCa classification in the analyzed cohorts. Docking and molecular dynamics simulations supported plausible binding compatibility of TCS to ABCC4 and ACOX2. Mendelian randomization suggested that genetically predicted ABCC4 expression may be associated with PCa risk. Single-cell analysis further showed cell-type-specific expression of candidate genes in tumor-enriched epithelial populations. These findings provide an integrative framework for generating mechanistic hypotheses on how TCS-related molecular targets may be associated with PCa biology.